Medical Dialogues2d
GLP-1 RA Use Linked to Lower Hematologic Cancer Risk in T2D Patients: JAMA
According to a study published in JAMA Network Open, among patients with type 2 diabetes (T2D), the use of glucagon-like ...
Targeted Oncology1d
Orca-T Improves cGVHD-Free Survival Across Hematologic Malignancies
Orca-T improved 1-year survival without severe graft-vs-host disease compared with standard transplant in the Precision-T ...
News-Medical.Net on MSN9d
GLP-1 drugs may cut risk of leukemia and lymphoma in type 2 diabetes patients
Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...
Renal & Urology News2d
Risk for Specific Hematologic Cancers Down With GLP-1 Receptor Agonist Use in T2DM
GLP-1 RA use linked to lower risks for myelodysplastic syndromes, myeloproliferative neoplasms compared with metformin. (HealthDay News) — For patients with type 2 diabetes (T2D), glucagon-like ...
Business Wire7d
Ionis and Ono announce global license agreement for sapablursen in polycythemia vera
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) and Ono Pharmaceutical Co., Ltd (Ono), today announced that the two companies have ...
The New England Journal of Medicine12d
Hematologic Aspects of Arsenic Intoxication
Recently, we have seen 2 patients with chronic arsenic intoxication that was difficult to recognize clinically and took the form of unusual, serious hematologic abnormalities. This stimulated us ...
Hosted on MSN9d
Risk for Specific Hematologic Cancers Down With GLP-1 Receptor Agonist Use in T2DM
MONDAY, March 10, 2025 (HealthDay News) -- For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist ...
Monthly Prescribing Reference8d
Risk for Specific Hematologic Cancers Down With GLP-1 Receptor Agonist Use in T2DM
HealthDay News — For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced risk for developing hematologic cancers compared ...